| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 57.3% | 64.9% | ▲ +7.6% |
| Healthcare Services | 29.1% | 20.4% | ▼ -8.7% |
| Insurance | 7.0% | 6.3% | ▼ -0.7% |
| Retailing | 1.4% | 1.6% | ▲ +0.2% |
| Healthcare Equipment & Supplies | 0.0% | 1.4% | ▲ +1.4% |
| IT - Services | 1.1% | 1.3% | ▲ +0.2% |
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 64.9% | 67.8% | ▲ +2.9% |
| Healthcare Services | 20.4% | 17.9% | ▼ -2.5% |
| Insurance | 6.3% | 7.3% | ▲ +1.0% |
| Retailing | 1.6% | 1.6% | ● +0.0% |
| IT - Services | 1.3% | 1.6% | ▲ +0.3% |
| Healthcare Equipment & Supplies | 1.4% | 1.1% | ▼ -0.3% |
Comparing Mar 2026 → Apr 2026
| # | Stock | Sector | Weight (Apr 2026) |
|---|---|---|---|
| 1 | Concord Biotech Limited ₹6.85 Cr |
Pharmaceuticals & Biotechnology | 1.29% |
| 2 | Procter & Gamble Health Limited ₹5.74 Cr |
Pharmaceuticals & Biotechnology | 1.08% |
| 3 | Max Financial Services Limited ₹5.55 Cr |
Insurance | 1.05% |
| 4 | Cohance Lifesciences Limited ₹5.10 Cr |
Pharmaceuticals & Biotechnology | 0.96% |
| # | Stock | Sector | Last Weight (Mar 2026) |
|---|---|---|---|
| 1 | Max Healthcare Institute Limited ₹12.03 Cr |
Healthcare Services | 2.33% |
| # | Stock | Sector | Mar 2026 | Apr 2026 | Change |
|---|---|---|---|---|---|
| 1 | Glenmark Pharmaceuticals Limited ₹14.44 Cr |
Pharmaceuticals & Biotechnology | 1.24% | 2.72% | +1.48% |
| 2 | Fortis Healthcare Limited ₹23.07 Cr |
Healthcare Services | 3.09% | 4.35% | +1.26% |
| 3 | Apollo Hospitals Enterprise Limited ₹22.91 Cr |
Healthcare Services | 3.24% | 4.32% | +1.08% |
| 4 | Laurus Labs Limited ₹25.32 Cr |
Pharmaceuticals & Biotechnology | 4.43% | 4.78% | +0.35% |
| 5 | Inventurus Knowledge Solutions Limited ₹8.27 Cr |
IT - Services | 1.29% | 1.56% | +0.27% |
| 6 | Divi's Laboratories Limited ₹10.99 Cr |
Pharmaceuticals & Biotechnology | 1.95% | 2.07% | +0.12% |
| 7 | AstraZeneca Pharma India Limited ₹21.35 Cr |
Pharmaceuticals & Biotechnology | 3.92% | 4.03% | +0.11% |
| 8 | Mankind Pharma Limited ₹6.74 Cr |
Pharmaceuticals & Biotechnology | 1.17% | 1.27% | +0.10% |
| 9 | Aurobindo Pharma Limited ₹13.90 Cr |
Pharmaceuticals & Biotechnology | 2.53% | 2.62% | +0.09% |
| 10 | Emcure Pharmaceuticals Limited ₹18.24 Cr |
Pharmaceuticals & Biotechnology | 3.36% | 3.44% | +0.08% |
| # | Stock | Sector | Mar 2026 | Apr 2026 | Change |
|---|---|---|---|---|---|
| 1 | Rainbow Childrens Medicare Limited ₹7.40 L |
Healthcare Services | 2.26% | 0.01% | -2.25% |
| 2 | Gland Pharma Limited ₹11.10 Cr |
Pharmaceuticals & Biotechnology | 2.96% | 2.09% | -0.87% |
| 3 | Sun Pharmaceutical Industries Limited ₹49.73 Cr |
Pharmaceuticals & Biotechnology | 10.23% | 9.38% | -0.85% |
| 4 | Dr. Reddy's Laboratories Limited ₹6.61 Cr |
Pharmaceuticals & Biotechnology | 1.58% | 1.25% | -0.33% |
| 5 | Poly Medicure Limited ₹5.76 Cr |
Healthcare Equipment & Supplies | 1.39% | 1.09% | -0.30% |
| 6 | Aster DM Healthcare Limited ₹15.77 Cr |
Healthcare Services | 3.25% | 2.97% | -0.28% |
| 7 | Abbott India Limited ₹27.98 Cr |
Pharmaceuticals & Biotechnology | 5.53% | 5.28% | -0.25% |
| 8 | Lupin Limited ₹32.27 Cr |
Pharmaceuticals & Biotechnology | 6.29% | 6.09% | -0.20% |
| 9 | Torrent Pharmaceuticals Limited ₹27.20 Cr |
Pharmaceuticals & Biotechnology | 5.32% | 5.13% | -0.19% |
| 10 | JB Chemicals & Pharmaceuticals Limited ₹22.48 Cr |
Pharmaceuticals & Biotechnology | 4.41% | 4.24% | -0.17% |
35 stocks — Apr 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹49.73 Cr |
Pharmaceuticals & Biotechnology |
9.38%
|
|
| 2 |
₹32.27 Cr |
Pharmaceuticals & Biotechnology |
6.09%
|
|
| 3 |
₹28.32 Cr |
Pharmaceuticals & Biotechnology |
5.34%
|
|
| 4 |
₹27.98 Cr |
Pharmaceuticals & Biotechnology |
5.28%
|
|
| 5 |
₹27.20 Cr |
Pharmaceuticals & Biotechnology |
5.13%
|
|
| 6 |
₹25.32 Cr |
Pharmaceuticals & Biotechnology |
4.78%
|
|
| 7 |
₹23.07 Cr |
Healthcare Services |
4.35%
|
|
| 8 |
₹22.91 Cr |
Healthcare Services |
4.32%
|
|
| 9 |
₹22.48 Cr |
Pharmaceuticals & Biotechnology |
4.24%
|
|
| 10 |
₹21.35 Cr |
Pharmaceuticals & Biotechnology |
4.03%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.